This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Northwest University. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2022
Title: Xirui He: Innovator in Pharmaceutical Chemistry
Introduction
Xirui He is a notable inventor based in Shaanxi, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
Xirui He holds two patents that showcase his innovative work. The first patent is for a tripeptide compound, along with its preparation method and application. This compound exhibits angiotensin-converting enzyme inhibiting bioactivity, which is crucial in preventing and treating hypertension and other diseases related to the cardiocerebral vascular system. The second patent pertains to α-asary-laldehyde ester, detailing its preparation method and applications. The chemical structure of this ester is also represented in the patent documentation.
Career Highlights
Xirui He is affiliated with Northwest University, where he continues to engage in research and development in his field. His work has garnered attention for its potential impact on health and medicine.
Collaborations
He has collaborated with notable colleagues, including Xiaohui Zheng and Fanggang Qin, contributing to a dynamic research environment.
Conclusion
Xirui He is a prominent figure in pharmaceutical innovation, with patents that reflect his commitment to advancing medical science. His contributions are poised to make a significant impact on healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
